Position in AXGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,710,060
+$10,515,885 QoQ
Shares Held
578,265
+18.3% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 253 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026VANGUARD PORTFOLIO MANAGEMENT LLC holds $22,355,506,884 across 76 Medical Devices names. AXGN ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
49,017,866 | $4,447,881,160 | |
| 2 | MDT |
Medtronic plc
|
34,059,967 | $2,664,511,218 | |
| 3 | SYK |
Stryker Corp
|
8,173,167 | $2,573,239,898 | |
| 4 | EW |
Edwards Lifesciences Corp
|
26,411,402 | $2,389,175,424 | |
| 5 | DXCM |
Dexcom Inc
|
19,656,540 | $1,323,867,969 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
20,275,526 | $1,297,836,419 | |
| 7 | BSX |
Boston Scientific Corp
|
29,792,794 | $1,271,556,447 | |
| 8 | STE |
STERIS plc
|
5,001,950 | $1,053,260,611 |
All Filings in AXGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,710,060 | 578,265 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,194,175 | 488,807 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||